Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 24 pages.
Return to Philippine COVID-19 Living Recommendations.
Rapid Review
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Covid-PSMID
PSMID would like to express its strong statement against the use of CHLOROQUINE or HYDROXCHLOROQUINE should not be used for prophylaxis.
There is no high quality evidence that these will prevent COVID19. These drugs should be used cautiously because of the possible side effects.
LET’S NOT TAKE AWAY STOCKS OF CHLOROQUINE FROM THOSE WHO REALLY NEED IT!
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.